These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Challenging the dose-response-time data approach: Analysis of a complex system. Andersson R; Jirstrand M; Almquist J; Gabrielsson J Eur J Pharm Sci; 2019 Feb; 128():250-269. PubMed ID: 30453011 [TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of rate and extent of tolerance of biomarkers: application to nicotinic acid-induced changes in non-esterified fatty acids in rats. Ahlström C; Peletier LA; Gabrielsson J Eur J Pharm Sci; 2011 Oct; 44(3):250-64. PubMed ID: 21856416 [TBL] [Abstract][Full Text] [Related]
11. Comparison of rat and dog models of vasodilatation and lipolysis for the calculation of a therapeutic index for GPR109A agonists. Carballo-Jane E; Gerckens LS; Luell S; Parlapiano AS; Wolff M; Colletti SL; Tata JR; Taggart AK; Waters MG; Richman JG; McCann ME; Forrest MJ J Pharmacol Toxicol Methods; 2007; 56(3):308-16. PubMed ID: 17643322 [TBL] [Abstract][Full Text] [Related]
12. Effect of AY-25,712 on fatty acid metabolism in rats. Cayen MN; Kallai-Sanfacon MA; Dubuc J; Greselin E; Dvornik D Atherosclerosis; 1982 Dec; 45(3):281-90. PubMed ID: 7159499 [TBL] [Abstract][Full Text] [Related]
13. Continuous 24-h nicotinic acid infusion in rats causes FFA rebound and insulin resistance by altering gene expression and basal lipolysis in adipose tissue. Oh YT; Oh KS; Choi YM; Jokiaho A; Donovan C; Choi S; Kang I; Youn JH Am J Physiol Endocrinol Metab; 2011 Jun; 300(6):E1012-21. PubMed ID: 21386057 [TBL] [Abstract][Full Text] [Related]
14. Hormonal and metabolic characteristics of genetically obese Zucker and dietary obese Sprague-Dawley rats. Nosadini R; Ursini F; Tessari P; Garotti MC; de Biasi F; Tiengo A Eur J Clin Invest; 1980 Apr; 10(2 Pt 1):113-8. PubMed ID: 6780357 [TBL] [Abstract][Full Text] [Related]
15. Pharmacological doses of niacin stimulate the expression of genes involved in carnitine uptake and biosynthesis and improve the carnitine status of obese Zucker rats. Couturier A; Ringseis R; Most E; Eder K BMC Pharmacol Toxicol; 2014 Jul; 15():37. PubMed ID: 25012467 [TBL] [Abstract][Full Text] [Related]
16. Response of genetically obese Zucker rats to ciprofibrate, a hypolipidemic agent, with peroxisome proliferation activity as compared to Zucker lean and Sprague-Dawley rats. Pacot C; Petit M; Caira F; Rollin M; Behechti N; Grégoire S; Cherkaoui Malki M; Cavatz C; Moisant M; Moreau C Biol Cell; 1993; 77(1):27-35. PubMed ID: 8518742 [TBL] [Abstract][Full Text] [Related]
17. Antilipolytic and lipolytic effects of administering free or ruminally protected nicotinic acid to feed-restricted Holstein cows. Pescara JB; Pires JA; Grummer RR J Dairy Sci; 2010 Nov; 93(11):5385-96. PubMed ID: 20965354 [TBL] [Abstract][Full Text] [Related]
18. Impaired long-chain fatty acid oxidation and contractile dysfunction in the obese Zucker rat heart. Young ME; Guthrie PH; Razeghi P; Leighton B; Abbasi S; Patil S; Youker KA; Taegtmeyer H Diabetes; 2002 Aug; 51(8):2587-95. PubMed ID: 12145175 [TBL] [Abstract][Full Text] [Related]
19. Role of plasma insulin concentration in regulating glucose and lipid metabolism in lean and obese Zucker rats. Noshiro O; Hirayama R; Shimaya A; Yoneta T; Niigata K; Shikama H Int J Obes Relat Metab Disord; 1997 Feb; 21(2):115-21. PubMed ID: 9043965 [TBL] [Abstract][Full Text] [Related]